Author: Afifa Zahid
-
Johnson & Johnson Vaccine Update
On February 27, the Food and Drug Administration approved Johnson & Johnson’s single dose COVID-19 vaccine. Johnson & Johnson now plans to ship approximately 20 million doses by the end of March. What do we know about this vaccine?
-
New Developments in Treating Mental Maladies
The growing conversation about mental health in the United States has sparked necessary change in treating mental health. However, as research into the health effects of mental health facilities becomes more accessible, the United States will be able to properly tackle the mental health crises.
-
The Historical Development of Fentanyl
Fentanyl has become one of the most valuable drugs for pain treatment throughout the world. Since its creation, fentanyl has been administered in a number of ways, including patches and sprays. Learn more about the studies, uses, and developments of this drug!
-
COVID-19 Vaccine Research and Development Update
For many, the only way out of the current COVID-19 pandemic is a vaccine. Yet, creating a vaccine this effective has been a particularly hard experience, not just scientifically, but emotionally for millions of people worldwide.
-
“Tree Man” Syndrome: The Rare Genetic Disorder
Epidermodysplasia Verruciformis, otherwise referred to as “Tree Man” syndrome in recent media coverage, is a growing interest in recent medical research. But what exactly is “tree man” syndrome and what does living with this condition entail?
-
Lab Grown Mini Brains and the Future of Neurology
Scientists attempting to grow human organs themselves are not an entirely new concept; in fact, scientists have been conducting this process for well over a decade, growing human organs ranging from kidneys to skin. Researchers have now been able to grow a mini-brain with neural activity that mirrors a preterm infant.
Youth Medical Journal 